Whittier Trust’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $71.4K | Hold |
1,469
| – | – | ﹤0.01% | 871 |
|
|
2025
Q1 | $50K | Hold |
1,469
| – | – | ﹤0.01% | 932 |
|
|
2024
Q4 | $57.8K | Sell |
1,469
-5
| -0.3% | -$197 | ﹤0.01% | 910 |
|
|
2024
Q3 | $69.2K | Hold |
1,474
| – | – | ﹤0.01% | 870 |
|
|
2024
Q2 | $79.6K | Buy |
1,474
+800
| +119% | +$43.2K | ﹤0.01% | 825 |
|
|
2024
Q1 | $45.9K | Hold |
674
| – | – | ﹤0.01% | 955 |
|
|
2023
Q4 | $42.2K | Hold |
674
| – | – | ﹤0.01% | 955 |
|
|
2023
Q3 | $30.6K | Hold |
674
| – | – | ﹤0.01% | 1026 |
|
|
2023
Q2 | $37.8K | Hold |
674
| – | – | ﹤0.01% | 990 |
|
|
2023
Q1 | $30.5K | Hold |
674
| – | – | ﹤0.01% | 1059 |
|
|
2022
Q4 | $27.4K | Buy |
674
+466
| +224% | +$18.9K | ﹤0.01% | 1078 |
|
|
2022
Q3 | $14K | Hold |
208
| – | – | ﹤0.01% | 1273 |
|
|
2022
Q2 | $13K | Hold |
208
| – | – | ﹤0.01% | 1265 |
|
|
2022
Q1 | $13K | Buy |
208
+9
| +5% | +$563 | ﹤0.01% | 1286 |
|
|
2021
Q4 | $15K | Sell |
199
-924
| -82% | -$69.6K | ﹤0.01% | 1241 |
|
|
2021
Q3 | $126K | Hold |
1,123
| – | – | ﹤0.01% | 731 |
|
|
2021
Q2 | $182K | Hold |
1,123
| – | – | ﹤0.01% | 675 |
|
|
2021
Q1 | $137K | Buy |
1,123
+924
| +464% | +$113K | ﹤0.01% | 713 |
|
|
2020
Q4 | $30K | Hold |
199
| – | – | ﹤0.01% | 951 |
|
|
2020
Q3 | $17K | Hold |
199
| – | – | ﹤0.01% | 1036 |
|
|
2020
Q2 | $15K | Hold |
199
| – | – | ﹤0.01% | 1009 |
|
|
2020
Q1 | $8K | Hold |
199
| – | – | ﹤0.01% | 1133 |
|
|
2019
Q4 | $12K | Hold |
199
| – | – | ﹤0.01% | 1101 |
|
|
2019
Q3 | $8K | Hold |
199
| – | – | ﹤0.01% | 1169 |
|
|
2019
Q2 | $9K | Hold |
199
| – | – | ﹤0.01% | 1086 |
|
|
2019
Q1 | $7K | Hold |
199
| – | – | ﹤0.01% | 1101 |
|
|
2018
Q4 | $6K | Hold |
199
| – | – | ﹤0.01% | 1151 |
|
|
2018
Q3 | $9K | Hold |
199
| – | – | ﹤0.01% | 1050 |
|
|
2018
Q2 | $12K | Buy |
+199
| New | +$12K | ﹤0.01% | 1000 |
|